Literature DB >> 22493035

Review of endophthalmitis following Boston keratoprosthesis type 1.

Marie-Claude Robert1, Krystel Moussally, Mona Harissi-Dagher.   

Abstract

Endophthalmitis remains one of the most damaging and challenging complications following Boston keratoprosthesis type 1 (KPro) surgery. The authors reviewed the literature from 2001 onward to identify cases of endophthalmitis following KPro surgery and present an additional case of endophthalmitis in a patient with Stevens Johnson syndrome. The prevalence of endophthalmitis between 2001 and 2011 was 5.4%. Gram-positive bacteria are the most common agents responsible for endophthalmitis in this patient population while gram-negative bacteria and fungi are emerging pathogens. Risk factors for endophthalmitis include preoperative diagnosis of cicatricial disease and postoperative infectious keratitis, glaucoma drainage device erosion and non-compliance with antibiotic prophylaxis. Additional studies on the prevention and treatment of endophthalmitis are required to improve the overall prognosis of these patients.

Entities:  

Mesh:

Year:  2012        PMID: 22493035     DOI: 10.1136/bjophthalmol-2011-301263

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  13 in total

1.  Effectiveness of antimicrobial peptide immobilization for preventing perioperative cornea implant-associated bacterial infection.

Authors:  Xiao Wei Tan; Tze Wei Goh; P Saraswathi; Chan Lwin Nyein; Melina Setiawan; Andri Riau; R Lakshminarayanan; Shouping Liu; Donald Tan; Roger W Beuerman; Jodhbir S Mehta
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

Review 2.  Fungal Infections After Boston Type 1 Keratoprosthesis Implantation: Literature Review and In Vitro Antifungal Activity of Hypochlorous Acid.

Authors:  Silvia Odorcic; Wolfgang Haas; Michael S Gilmore; Claes H Dohlman
Journal:  Cornea       Date:  2015-12       Impact factor: 2.651

3.  Wide-field vitreoretinal surgery in eyes with Boston type 1 keratoprosthesis.

Authors:  Canan Asli Utine; Mahmut Kaya; Kıvanç Kasal
Journal:  Int Ophthalmol       Date:  2021-10-12       Impact factor: 2.031

4.  Current Concepts in the Management of Unique Post-keratoplasty Infections.

Authors:  Julie M Schallhorn; Jennifer Rose-Nussbaumer
Journal:  Curr Ophthalmol Rep       Date:  2015-06-12

5.  COMPARISON OF VISUAL AND ANATOMICAL OUTCOMES OF EYES UNDERGOING TYPE I BOSTON KERATOPROSTHESIS WITH COMBINATION PARS PLANA VITRECTOMY WITH EYES WITHOUT COMBINATION VITRECTOMY.

Authors:  Jennifer I Lim; Lindsay Machen; Andrea Arteaga; Faris I Karas; Robert Hyde; Dingcai Cao; Marcia Niec; Thasarat S Vajaranant; M Soledad Cortina
Journal:  Retina       Date:  2018-09       Impact factor: 4.256

Review 6.  Keratoprostheses for corneal blindness: a review of contemporary devices.

Authors:  Venkata S Avadhanam; Helen E Smith; Christopher Liu
Journal:  Clin Ophthalmol       Date:  2015-04-16

7.  Streptococcus agalactiae Endophthalmitis in Boston Keratoprosthesis in a Patient with Steven-Johnson Syndrome.

Authors:  Humoud M Al-Otaibi; Mohammed Talea; Omar Kirat; Donald U Stone; William N May; Igor Kozak
Journal:  Middle East Afr J Ophthalmol       Date:  2016 Oct-Dec

8.  Bacterial Contamination of Multi-dose Eye Drops at Ophthalmology Department, University of Gondar, Northwest Ethiopia.

Authors:  Asegedech Tsegaw; Asamere Tsegaw; Tefera Abula; Yared Assefa
Journal:  Middle East Afr J Ophthalmol       Date:  2017 Apr-Jun

9.  Boston type I keratoprosthesis-donor cornea interface evaluated by high-definition spectral-domain anterior segment optical coherence tomography.

Authors:  Ana G Alzaga Fernandez; Nathan M Radcliffe; Kimberly C Sippel; Mark I Rosenblatt; Priyanka Sood; Christopher E Starr; Jessica B Ciralsky; Donald J D'Amico; Szilárd Kiss
Journal:  Clin Ophthalmol       Date:  2012-08-27

Review 10.  Boston keratoprosthesis - Clinical outcomes with wider geographic use and expanding indications - A systematic review.

Authors:  Khalid Al Arfaj
Journal:  Saudi J Ophthalmol       Date:  2015-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.